SELECT FROM MENU

Therapy Area
Drug Classes

       Disease Area

All Sessions

All Sessions

All Sessions

Resectable NSCLC

All Sessions

Metastatic NSCLC

All Sessions

SCLC

All Sessions

Biomarkers

       Drug Class

Targeted Therapies

Targeted Therapies

Immuno-therapies

Immuno-therapies

Antibody-Drug Conjugates

Antibody-Drug Conjugates

Therapy Area
Drug Classes

       Disease Area

All Sessions

All Sessions

All Sessions

Resectable NSCLC

All Sessions

Metastatic NSCLC

All Sessions

SCLC

All Sessions

Biomarkers

       Drug Class

Targeted Therapies

Targeted Therapies

Immuno-therapies

Immuno-therapies

Antibody-Drug Conjugates

Antibody-Drug Conjugates

All
FEATURED
ILCS
Webinars
Articles

       Industry Sponsored

Featured Sessions

Sep 26 2025

THE ROLE OF IO ADDED TO CHEMORADIATION IN UNRESECTABLE STAGE III NSCLC

} 28 min

Read More
Sep 26 2025

TAILORING IO IN RES. NSCLC: PERSONALIZED APPROACHES FOR IMPROVED OUTCOMES

} 36 min

Read More
Jordi Remon
Oct 04 2024

Tailoring IO in Resectable NSCLC: Personalized Approaches for Improved Outcomes

} 25 min

Read More

       From Our Annual Summit

ILCS Sessions

Sep 26 2025

THE ROLE OF IO ADDED TO CHEMORADIATION IN UNRESECTABLE STAGE III NSCLC

} 28 min
Sep 26 2025

TAILORING IO IN RES. NSCLC: PERSONALIZED APPROACHES FOR IMPROVED OUTCOMES

} 36 min
Jordi Remon
Oct 04 2024

Tailoring IO in Resectable NSCLC: Personalized Approaches for Improved Outcomes

} 25 min

       Expert Insights

Webinars

Lung Cancer Review by Solange Peters, Martin Reck, Charles Rudin
Dec 18 2025

2025 Approvals & Highlights

} 1 h 49 min
IO in NSCLC by Solange Peters, Jordi Remon, Patrick Forde
Jun 25 2025

Immunotherapies in NSCLC

} 1h 47 min
SCLC by Solange Peters, Giannis Mountzios, Jacob Sands
Jun 17 2025

Small Cell Lung Cancer

} 1h 35 min

       The Reading Room

Articles & Research

Sep 20 2024
OncoNews

Bridging The Gap In Thoracic Oncology: What To Expect From The 6th ILCS

[et_pb_section fb_built ="1" admin_label ="section" _builder_version ="4.27.4" background_color ="#f5f8fb" positioning ="none" z_index ="0" custom_padding ="0px||0px|||" global_colors_info ="{}" theme_builder_area ="post_content"][et_pb_row admin_label ="row" _builder_version ="4.27.4" background_size ="initial" background_position ="top_left" background_repeat ="repeat" width...

       Industry Sponsored

Featured Sessions

Sep 26 2025

THE ROLE OF IO ADDED TO CHEMORADIATION IN UNRESECTABLE STAGE III NSCLC

} 28 min

Read More
Sep 26 2025

TAILORING IO IN RES. NSCLC: PERSONALIZED APPROACHES FOR IMPROVED OUTCOMES

} 36 min

Read More
Jordi Remon
Oct 04 2024

Tailoring IO in Resectable NSCLC: Personalized Approaches for Improved Outcomes

} 25 min

Read More

       From Our Annual Summit

ILCS Sessions

Sep 26 2025

THE ROLE OF IO ADDED TO CHEMORADIATION IN UNRESECTABLE STAGE III NSCLC

} 28 min
Sep 26 2025

TAILORING IO IN RES. NSCLC: PERSONALIZED APPROACHES FOR IMPROVED OUTCOMES

} 36 min
Jordi Remon
Oct 04 2024

Tailoring IO in Resectable NSCLC: Personalized Approaches for Improved Outcomes

} 25 min

       Expert Insights

Webinars

Lung Cancer Review by Solange Peters, Martin Reck, Charles Rudin
Dec 18 2025

2025 Approvals & Highlights

} 1 h 49 min
IO in NSCLC by Solange Peters, Jordi Remon, Patrick Forde
Jun 25 2025

Immunotherapies in NSCLC

} 1h 47 min
SCLC by Solange Peters, Giannis Mountzios, Jacob Sands
Jun 17 2025

Small Cell Lung Cancer

} 1h 35 min

       The Reading Room

Articles & Research

Sep 20 2024
OncoNews

Bridging The Gap In Thoracic Oncology: What To Expect From The 6th ILCS

[et_pb_section fb_built ="1" admin_label ="section" _builder_version ="4.27.4" background_color ="#f5f8fb" positioning ="none" z_index ="0" custom_padding ="0px||0px|||" global_colors_info ="{}" theme_builder_area ="post_content"][et_pb_row admin_label ="row" _builder_version ="4.27.4" background_size ="initial" background_position ="top_left" background_repeat ="repeat" width...

Indication Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immunotherapies

Antibody Drug Conjugates

Antibody-Drug Conjugates